BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18319590)

  • 1. 14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk.
    Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Fernández-Viadero C; Peña N; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2008; 25(4):317-20. PubMed ID: 18319590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk.
    Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Berciano J; Combarros O
    Eur J Neurol; 2008 Mar; 15(3):219-22. PubMed ID: 18290843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in tau-tubulin kinase-1 are linked to Alzheimer's disease in a Spanish case-control cohort.
    Vázquez-Higuera JL; Martínez-García A; Sánchez-Juan P; Rodríguez-Rodríguez E; Mateo I; Pozueta A; Frank A; Valdivieso F; Berciano J; Bullido MJ; Combarros O
    Neurobiol Aging; 2011 Mar; 32(3):550.e5-9. PubMed ID: 20096481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
    Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
    Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
    J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the tau kinases pathway may modify the risk and age at onset of Alzheimer's disease.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Calero M; Dobato JL; Frank-García A; Valdivieso F; Berciano J; Bullido MJ; Combarros O
    J Alzheimers Dis; 2011; 27(2):291-7. PubMed ID: 21811019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women.
    Fontalba A; Gutiérrez O; Llorca J; Mateo I; Berciano J; Fernández-Luna JL; Combarros O
    Dement Geriatr Cogn Disord; 2008; 26(3):247-50. PubMed ID: 18841008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
    Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
    Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
    Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
    Andersson ME; Sjölander A; Andreasen N; Minthon L; Hansson O; Bogdanovic N; Jern C; Jood K; Wallin A; Blennow K; Zetterberg H
    Int J Mol Med; 2007 Aug; 20(2):233-9. PubMed ID: 17611642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of heme oxygenase-1 and tau genetic variants on Alzheimer's disease risk.
    Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Vázquez-Higuera JL; García-Gorostiaga I; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2008; 26(4):339-42. PubMed ID: 18841019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extended tau haplotype and the age of onset of dementia in Down syndrome.
    Jones EL; Margallo-Lana M; Prasher VP; Ballard CG
    Dement Geriatr Cogn Disord; 2008; 26(3):199-202. PubMed ID: 18765933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
    Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
    Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians.
    Scacchi R; Pinto A; Gambina G; Rosano A; Corbo RM
    Brain Res; 2007 Mar; 1139():1-5. PubMed ID: 17270153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A; Boom A; Leroy K; Brion JP
    FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
    Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
    Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the LOC387715/ARMS2 putative gene and the risk for Alzheimer's disease.
    Gatta LB; Vitali M; Zanola A; Venturelli E; Fenoglio C; Galimberti D; Scarpini E; Finazzi D
    Dement Geriatr Cogn Disord; 2008; 26(2):169-74. PubMed ID: 18688167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.